neomycin selection marker (TaKaRa)
Structured Review
Neomycin Selection Marker, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 3506 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/neomycin+selection+marker/Puromycin/bio_rxiv__2025__06__13__659598-168-86-98
Average 96 stars, based on 3506 article reviews
Images
Related Articles
Retroviral:Article Title: Regulation of p38 Phosphorylation and Topoisomerase IIα Expression in the B-Cell Lymphoma Line Jiyoye by CD26/Dipeptidyl Peptidase IV Is Associated with Enhanced In vitro and In vivo Sensitivity to Doxorubicin Article Snippet: .. After the sequences were confirmed, CD26 or CD26S630A fragment was inserted into retroviral vector pLNCX2 containing a Article Title: The nucleus activates mechano-responsiveness via FHOD-associated LINC complexes Article Snippet: This plasmid was used to transfect 293T for the overexpression of protein. pMSCV-neo MYC-C4 retroviral vector was derived from pMSCV-puro myc vector by replacing the puromycin selectable marker with a neomycin selectable marker from pEGFP-C4 plasmid (Clontech). .. This plasmid was used to make retroviral particles in 293T cells and to express amino terminal MYC tagged protein in mammalian cells. pInducer200 (puro) tet-on EGFP-C4 plasmid was derived from pInducer20 plasmid (Addgene #44012) by: 1) by replacing the tetracycline inducible minimal CMV promoter with the TRE3G promoter from LT3GPIR plasmid (Addgene #111177), 2) inserting EGFP cDNA from pEGFP-C4 (Clontech) plasmid in the downstream of TRE3G promoter, 3) replacing the UbC promoter with the human PGK promoter from pCW-Cas9-Blast plasmid (Addgene #83481), and 4) replacing the Plasmid Preparation:Article Title: Regulation of p38 Phosphorylation and Topoisomerase IIα Expression in the B-Cell Lymphoma Line Jiyoye by CD26/Dipeptidyl Peptidase IV Is Associated with Enhanced In vitro and In vivo Sensitivity to Doxorubicin Article Snippet: .. After the sequences were confirmed, CD26 or CD26S630A fragment was inserted into retroviral vector pLNCX2 containing a Article Title: The nucleus activates mechano-responsiveness via FHOD-associated LINC complexes Article Snippet: This plasmid was used to transfect 293T for the overexpression of protein. pMSCV-neo MYC-C4 retroviral vector was derived from pMSCV-puro myc vector by replacing the puromycin selectable marker with a neomycin selectable marker from pEGFP-C4 plasmid (Clontech). .. This plasmid was used to make retroviral particles in 293T cells and to express amino terminal MYC tagged protein in mammalian cells. pInducer200 (puro) tet-on EGFP-C4 plasmid was derived from pInducer20 plasmid (Addgene #44012) by: 1) by replacing the tetracycline inducible minimal CMV promoter with the TRE3G promoter from LT3GPIR plasmid (Addgene #111177), 2) inserting EGFP cDNA from pEGFP-C4 (Clontech) plasmid in the downstream of TRE3G promoter, 3) replacing the UbC promoter with the human PGK promoter from pCW-Cas9-Blast plasmid (Addgene #83481), and 4) replacing the Marker:Article Title: Regulation of p38 Phosphorylation and Topoisomerase IIα Expression in the B-Cell Lymphoma Line Jiyoye by CD26/Dipeptidyl Peptidase IV Is Associated with Enhanced In vitro and In vivo Sensitivity to Doxorubicin Article Snippet: .. After the sequences were confirmed, CD26 or CD26S630A fragment was inserted into retroviral vector pLNCX2 containing a Article Title: The nucleus activates mechano-responsiveness via FHOD-associated LINC complexes Article Snippet: This plasmid was used to transfect 293T for the overexpression of protein. pMSCV-neo MYC-C4 retroviral vector was derived from pMSCV-puro myc vector by replacing the puromycin selectable marker with a neomycin selectable marker from pEGFP-C4 plasmid (Clontech). .. This plasmid was used to make retroviral particles in 293T cells and to express amino terminal MYC tagged protein in mammalian cells. pInducer200 (puro) tet-on EGFP-C4 plasmid was derived from pInducer20 plasmid (Addgene #44012) by: 1) by replacing the tetracycline inducible minimal CMV promoter with the TRE3G promoter from LT3GPIR plasmid (Addgene #111177), 2) inserting EGFP cDNA from pEGFP-C4 (Clontech) plasmid in the downstream of TRE3G promoter, 3) replacing the UbC promoter with the human PGK promoter from pCW-Cas9-Blast plasmid (Addgene #83481), and 4) replacing the Derivative Assay:Article Title: The nucleus activates mechano-responsiveness via FHOD-associated LINC complexes Article Snippet: This plasmid was used to transfect 293T for the overexpression of protein. pMSCV-neo MYC-C4 retroviral vector was derived from pMSCV-puro myc vector by replacing the puromycin selectable marker with a neomycin selectable marker from pEGFP-C4 plasmid (Clontech). .. This plasmid was used to make retroviral particles in 293T cells and to express amino terminal MYC tagged protein in mammalian cells. pInducer200 (puro) tet-on EGFP-C4 plasmid was derived from pInducer20 plasmid (Addgene #44012) by: 1) by replacing the tetracycline inducible minimal CMV promoter with the TRE3G promoter from LT3GPIR plasmid (Addgene #111177), 2) inserting EGFP cDNA from pEGFP-C4 (Clontech) plasmid in the downstream of TRE3G promoter, 3) replacing the UbC promoter with the human PGK promoter from pCW-Cas9-Blast plasmid (Addgene #83481), and 4) replacing the Selection:Article Title: The nucleus activates mechano-responsiveness via FHOD-associated LINC complexes Article Snippet: This plasmid was used to transfect 293T for the overexpression of protein. pMSCV-neo MYC-C4 retroviral vector was derived from pMSCV-puro myc vector by replacing the puromycin selectable marker with a neomycin selectable marker from pEGFP-C4 plasmid (Clontech). .. This plasmid was used to make retroviral particles in 293T cells and to express amino terminal MYC tagged protein in mammalian cells. pInducer200 (puro) tet-on EGFP-C4 plasmid was derived from pInducer20 plasmid (Addgene #44012) by: 1) by replacing the tetracycline inducible minimal CMV promoter with the TRE3G promoter from LT3GPIR plasmid (Addgene #111177), 2) inserting EGFP cDNA from pEGFP-C4 (Clontech) plasmid in the downstream of TRE3G promoter, 3) replacing the UbC promoter with the human PGK promoter from pCW-Cas9-Blast plasmid (Addgene #83481), and 4) replacing the |
